Skip to main content
. 2015 Jul 20;33(32):3750–3758. doi: 10.1200/JCO.2014.60.3969

Fig 3.

Fig 3.

Maximum change in modified Severity Weighted Assessment Tool (mSWAT) by tissue CD30max (maximum level of CD30 expression) assessed by immunohistochemistry, stratified by disease stage and global clinical response. Data support a correlation between skin CD30max and depth of skin response (reduction in mSWAT; P = .0031).The dotted line depicts CD30max of 5%. Patients with CD30max of < 5% had a significantly lower likelihood of clinical response (P = .0046).